CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

0.9300

24-January-25 15:45:00

15 minutes delayed

Stocks

-0.0032

-0.34%

Today's range

0.9000 - 0.9434

ISIN

N/A

Source

NASDAQ

Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021

23 Feb 2021 06:05:00 By Nasdaq GlobeNewswire
Clearside Biomedical Announces CLS-AX (axitinib injectable suspension) Presentation Delivered at Angiogenesis, Exudation, and Degeneration 2021 Program

16 Feb 2021 06:05:00 By Nasdaq GlobeNewswire
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting

08 Feb 2021 06:05:00 By Nasdaq GlobeNewswire
Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD

12 Jan 2021 06:05:00 By Nasdaq GlobeNewswire
Clearside Biomedical Announces Pricing of $12 Million Registered Direct Offering

06 Jan 2021 06:05:00 By Nasdaq GlobeNewswire

<<
<
3
4
5
6
7
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.